• Intern Series (4)

    We’re pleased to share the latest in our series of posts from our interns. Daniel Ohrenstein has just completed an extended 5-month stay with us working on some exciting new techniques for multiple risk factor modelling. Daniel Ohrenstein I recently completed an MSc in Machine Learning and Data Science at UCL, having graduated with a […]

  • Why we must work toward a recognised international standard in evaluation of upstream interventions

    New blog published this week by Evidence & Policy co-authored by our COO and Co-Founder Laura Webber. The blog builds off research by Laura and collaborators at Lancaster University and the University of York on the health impacts universal basic income (UBI) could have. The role of UBI has come to the fore during the […]

  • NEWS: Making Conversations Count – The health and economic benefits of improving smoking cessation support in the UK

    Today, Cancer Research UK has published a new report Making Conversations Work: The health and economic benefits of improving smoking cessation support in UK general practice which includes modelling conducted by HealthLumen. The report found that by 2039 improved delivery of stop smoking support in general practice in the UK could prevent: > 400,000 cases of smoking-related […]

  • 2020 Summer Intern Series (3)

    As we move into the autumn, we’re pleased to share the last in our series of posts from some of our first summer interns. Annie Estlin I recently graduated from the University of Cambridge with an MPhil in Epidemiology. It’s been incredibly exciting to work for HealthLumen this summer and apply my learning in the […]

  • 2020 Summer Intern Series (2)

    In the next installment of our summer intern series, we hear about the “day in the life” of one of our interns.    Yousef El-Tawil Hello! I am a medical student by background at Kings College London and I am currently completing my intercalated MSc in Global Health Policy at the London School of Economics. […]

  • 2020 Summer Intern Series (1)

    Like everyone else, the HealthLumen team has been working hard these last few months to continue our work and navigate the new realities of a COVID-19 world. We have written about the role of modelling in post-COVID-19 decision making and have been working with various partners on the links between NCDs and COVID-19 outcomes. Despite […]

  • NEWS: Estimating the burden of CKD in the UK

    This week HealthLumen in partnership with AstraZeneca presented new work on the burden of chronic kidney disease (CKD) in the UK at the ERA-EDTA 2020 Congress. The study aims to compare and validate two different approaches to estimating the burden of CKD in the UK, and to estimate how this is predicted to change by […]

  • Happy Birthday to us…

    Today is a year since HealthLumen was founded. And, despite the current situation, we are fortunate that we have much to celebrate. To get the company launched we completed a successful transaction with the UK Health Forum, taking ownership of a powerful microsimulation platform with a 12-year track record of modelling non-communicable diseases and the […]

  • Simulating the future: The role of computer modelling in a post-COVID-19 world

    In collaboration with our charity partner The Royal Society for Public Health. Our COO and Co-Founder Laura Webber has set out the role of computer modelling in decision making in the post-COVID-19 world. Our first guest blog for RSPH. For further resources on COVID-19 please visit the RSPH COVID-19 hub. This resource is being updated […]

  • NEWS: Long-term health impacts of changing air pollution exposure in London

    Today, the Mayor of London published a HealthLumen report commissioned by Transport for London and the Greater London Authority modelling the long-term health impacts of changing exposure to NO2 and PM2.5 in London.   The report reveals that by 2050 the impact of current air quality policies, including the London Environment Strategy are predicted to result […]